303
Participants
Start Date
May 31, 2012
Primary Completion Date
September 30, 2012
Study Completion Date
November 30, 2012
LEO 90100
Calcipotriol
Betamethasone
Derm Research Center of New York, Stony Brook
Philadelphia Institute of Dermatology, Fort Washington
Virginia Clinical Research, Inc., Norfolk
North Florida Dermatology Associates, PA, Jacksonville
Dermatology Associates and Research, Coral Gables
International Dermatology Research, Inc., Miami
Owensboro Dermatology Associates, Owensboro
The Indiana Clinical Trials Center, Plainfield
Dawes Fretzin Clinical Research Group, Indianapolis
Clinical Research Advantage, Inc./Hudson Dermatology, LLC, Evansville
Grekin Skin Institute, Warren
Derm Center, Troy
David Fivenson, MD, PLC, Ann Arbor
Great Lakes Research Group, Inc., Bay City
Minnesota Clinical Study Center, Fridley
Altman Dermatology Associates, Arlington Heights
Glazer Dermatology, Buffalo Grove
Burke Pharmaceutical Research, Hot Springs
Menter Dermatology Research Institute, Dallas
Center for Clinical Studies, Houston
Clinical Trials of Texas, Inc, San Antonio
Dermatology Clinical Research Center of San Antonio, San Antonio
Progressive Clinical Research, San Antonio
Colorado Medical Research Center, Inc, Denver
Horizons Clinical Research Center, Denver
Dermatology Research Associates, Los Angeles
Clinical Science Institute, Santa Monica
Dermatology Specialists, Inc., Oceanside
Skin Surgery Medical Group, Inc, San Diego
University Clinical Trials, Inc., San Diego
Premier Clinical Research, Spokane
Psoriasis Treatment Center of Central NJ, East Windsor
The Dermatology Group, PC, Verona
Lead Sponsor
LEO Pharma
INDUSTRY